September 3, 2014 — Teleflex announced a newly published clinical study demonstrating the accuracy of the Arrow VPS G4 vascular positioning system, with placements of peripherally inserted central catheters (PICCs), can eliminate the use of confirmatory chest X-rays.

The easy-to-use online resource mHealth Roadmap includes information on implementation guidelines for mobile and mHealth strategies and applications. Topics covered in the Healthcare Information and Management Systems Society (HIMSS) mHealth Roadmap include:

Philips has launched Affiniti. The new ultrasound system made its debut at the European Society of Cardiology (ESC) Congress 2014 in Barcelona.

September 2, 2014 — Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-controlled clinical trial investigating vagus nerve stimulation (VNS) for the treatment of heart failure (HF) patients.

September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein isolation ablation in patients with AF and hypertension, according to research presented at the European Society of Cardiology (ESC) Congress by Alexander Romanov, M.D., from Russia.

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced results from the X-VeRT trial, demonstrating once-daily rivaroxaban may be an alternative to vitamin K antagonists in treating and reducing the risk of blood clots in non-valvular atrial fibrillation patients undergoing elective cardioversion, a common medical procedure to reset the heartbeat back to a regular rhythm. 

John Muir Health's Concord medical center is the first hospital in Northern California and one of just 20 hospitals in the nation to begin treating patients who suffer from atrial fibrillation (AFib), the most common type of heart arrhythmia, with a new procedure that features the FDA cleared FIRMap Catheter.

Subscribe Now